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Abstract: Ernest Duchesne (1874–1912) completed his thesis on microbial antagonism in 
1897 in Lyon. His work lay unknown for fifty years, but on being brought to light led to his 
being credited with having discovered penicillin prior to Alexander Fleming. The claims 
surrounding Duchesne are examined here both from the strictly microbiological perspective, 
and also for what they reveal about how the process of discovery is frequently misconstrued. 
The combined weight of evidence presented here militates strongly against the possibility that 
the species of Penicillium that Duchesne worked with produced penicillin. 
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Introduction 
Following the appearance of an article on penicillin in The Times of London in the summer of 
1942,1 Almroth Wright, head of the inoculation department at St Mary’s Hospital in 
Paddington, wrote to the editor concerning a colleague of his—a certain Alexander Fleming. 
In his letter, Wright pointed out that the newspaper had “refrained from putting the laurel 
wreath around anybody’s brow for [penicillin’s] discovery” and that “on the principle of 
palmam qui meruit ferat (let him bear the palm who has earned it) it should be decreed to 
Professor Fleming.”2 A number of commentators over the seventy years or so that have 
elapsed since the publication of this letter have sought to remove—snatch even—the wreath 
from Alexander Fleming’s brow and award it elsewhere. This article addresses attempts of 
this sort made by those who have proposed that the rightful recipient should in fact be Ernest 
Duchesne.  
Duchesne (1874–1912) undertook research on microbial antagonism in Lyon and 
published his thesis on the subject in 1897 whereupon he joined the French army as a 
physician. The following examines claims relating to Duchesne from two perspectives; that 
based on an analysis of the details of Duchesne’s experiments as set down in his thesis, and 
also from the wider perspective of what making a scientific discovery actually entails. The 
former are set alongside the most recent findings relating both to the taxonomy of the genus 
Penicillium and to the nature of metabolites elaborated by the penicillia. Also included are 
considerations that relate to the species of animal—guinea pigs—with which Duchesne 
conducted his in vivo experiments, as these enable a definitive judgement to be made 
regarding whether or not he was working with crude penicillin preparations.  
                                            
1 “Penicillium,” The Times, August 27, 1942, 5. 
2 Almroth Wright, “Letter to the Editor,” The Times, August 31, 1942, 5. 
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Consideration of what constitutes a scientific discovery is made with specific 
reference to the work on this subject by that philosopher of science, Thomas Kuhn. Briefly, 
Kuhn’s definition a discovery involves both recognizing that something is and, most crucially, 
what it is.3 Reference to these criteria shall be applied throughout this article where 
appropriate. 
Does it matter who is credited with the discovery of penicillin? It is surely sufficient 
to acknowledge that the antibiotic has saved countless lives. The answer to this question is 
important because accounts of the discovery of penicillin are used in a number of ways and 
for different purposes. Many such accounts distort and misrepresent the actual process by 
which penicillin came to be made available as a chemotherapeutic agent, and by extension, 
the very process of discovery itself. Such misrepresentations are not necessarily without 
wider consequences, as the examples given below show. 
In a biology textbook aimed at fifteen- to sixteen-year-old British schoolchildren, the 
authors inform their readers that “Alexander [Fleming] was rather careless,”4 when in fact, as 
will be demonstrated below, nothing could be further from the truth: he was rather the 
epitome of the meticulous researcher who deliberately broke the rules in order to court the 
consequences. Robert Bud identifies another misleading pronouncement, this time in a 
newspaper.5 A columnist in London’s Evening Standard criticized the massive expenditure 
on medical research, claiming that most drugs were discovered by accident. To support his 
                                            
3 Thomas S. Kuhn, “Historical Structure of Scientific Discovery,” Science 136 (1962): 760–
64. 
4 Ann Fullick, Margaret Cross, and Faye Meek, AQA Certificate in Biology (iGCSE) 
(Cheltenham: Nelson Thornes, 2011), 35. 
5 Robert Bud, “Penicillin and the New Elizabethans,” British Journal for the History of 
Science 31 (1998): 305–33. 
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argument he simply quoted the word “penicillin.” Finally, in a debate in the British House of 
Commons in November 1997 on college fees at the universities of Oxford and Cambridge, 
Evan Harris, a Liberal Democrat Member of Parliament, proclaimed, “penicillin was 
discovered in an Oxford laboratory.”6 It is surely important to ensure that schoolchildren, the 
public at large, and ultimately policymakers, should have a true appreciation and 
understanding of how scientific discoveries are made.  
 
The Development of Penicillin as a Chemotherapeutic Agent 
The events following the celebrated observation made by Alexander Fleming in the late 
summer of 1928 in which he witnessed the bacteriolytic action of a mold belonging to the 
genus Penicillium toward Staphylococcus aureus are generally well known, and have been 
related not only in the biographies of Fleming (see, for example, Gwyn Macfarlane’s 1985 
life)7 but also in those of the principal characters who were subsequently instrumental in 
developing penicillin as a chemotherapeutic agent. Notwithstanding, I will briefly set them 
out here to provide a point of reference.  
Having isolated the mold, Fleming cultured it in broths but failed to purify the active 
principle (i.e. the penicillin) from such liquid cultures. The general consensus is that as a 
consequence of this he totally lost interest in penicillin and conducted no further work on it, 
but evidence has been brought to light that in fact he continued to maintain an interest in 
                                            
6 Hansard, “Oxford and Cambridge College Fees,” accessed May 12, 2016, 
http://hansard.millbanksystems.com/commons/1997/nov/19/oxford-and-cambridge-college-
fees#S6CV0301P0_19971119_HOC_79.  
7 Gwyn Macfarlane, Alexander Fleming: The Man and the Myth (Oxford: Oxford University 
Press, 1985). 
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penicillin throughout the 1930s.8 Nor did Fleming refrain from mentioning his work on 
penicillin to others. C. G. Paine attended medical school at St Mary’s in London and received 
lectures from Fleming.9 He subsequently obtained a post at the Sheffield Royal Infirmary 
where he maintained contact with Fleming and obtained a culture of Penicillium from him, 
which he used at the end of 1930 and beginning of 1931 to treat infections—primarily of the 
eye—with crude filtrates.  
It was a decade after Fleming’s original observation when the pathologist Howard 
Florey and his colleagues at the Sir William Dunn School of Pathology at the University of 
Oxford decided to investigate the phenomenon of microbial antagonism. Of the handful of 
candidate substances they had shortlisted for potential further study, they happened to start 
with penicillin. Milton Wainwright and Harold T. Swan put forward convincing evidence in 
1986 that Paine may have acted in what was in effect a “go between” for Fleming and 
Florey.10 Prior to taking up his post at Oxford, Florey had been at Sheffield at the same time 
as Paine and was aware of his attempts to treat infections using crude filtrates. The Oxford 
team made rapid progress with culturing the mold on what might be termed the “pilot scale” 
and in purifying the penicillin, which led to their demonstration of penicillin’s therapeutic 
potential.  
Instrumental in solving the problem of extracting penicillin from crude mold broths—
a feat that had defeated Fleming and his assistants—was the participation of the German 
émigré biochemist, Ernst Chain. The group’s successes were rapidly capitalized upon and 
                                            
8 Milton Wainwright, “Fleming’s Unfinished,” Perspectives in Biology and Medicine 45 
(2002): 529–38. 
9 Milton Wainwright and Harold T. Swan, “C. G. Paine and the Earliest Surviving Clinical 
Records of Penicillin Therapy,” Medical History 30 (1986): 42–56.  
10 Ibid. 
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directly gave rise to the massive Anglo-American program for the bulk production of 
penicillin during the Second World War, which involved both academic researchers and the 
pharmaceutical industry. In 1945, Fleming, Florey, and Chain were awarded the Nobel Prize 
in Physiology or Medicine for “the discovery of penicillin and its curative effect in various 
infectious diseases.”11  
 
The Work of Ernest Duchesne 
Before considering the evidence for the claims surrounding Duchesne and penicillin in 
greater detail it will prove useful to provide a short biography of his life and a brief 
description of his work. Ernest Duchesne was born in Paris on May 30, 1874, the son of a 
chemical engineer who owned a tannery.12 On completing his secondary school studies he 
gained admittance to the École du Service de Santé Militaire in Lyon in 1894. In 1896 he 
began his research under the supervision of Professor Gabriel Roux who also held the post of 
Director of the Municipal Office of Hygiene for Lyon.  
Roux had been the author, in 1892, of a textbook on the microbiological analysis of 
water.13 He had observed, and become intrigued by, the fact that whereas mold spores were 
found in abundance in the air, they were absent from both tap water and fountain water, 
although they could be induced to grow in distilled water. He wondered whether such waters 
contained certain microorganisms that somehow prevented the growth of molds and set 
                                            
11 “The Nobel Prize in Physiology or Medicine 1945,” Nobelprize.org, accessed May 22, 
2016, https://www.nobelprize.org/nobel_prizes/medicine/laureates/1945/. 
12 Jean Pouillard, “Une découverte oubliée: la thèse de médecine du docteur Ernest Duchesne 
(1874–1912),” Historie des Sciences Médicales 36 (2002): 11–20. 
13 Gabriel Roux, Precis d’Analyse Microbiologique des Eaux (Paris: J.-B. Ballière et fils, 
1892). 
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Duchesne to work on this topic. Duchesne defined this problem explicitly in evolutionary 
terms. He referred directly to Darwin and his theory of evolution by natural selection in the 
first line of the opening chapter in his thesis.14   
Darwin’s magnum opus On the Origin of Species was published in 1859. Clémence 
Royer’s French translation appeared in 1862 as De l'Origine des Espèces ou des Lois du 
Progrès chez les Êtres Organisés. She rendered Darwin’s English phrase “struggle for life”—
the title of chapter three—as “concurrence vitale”.15  That term appeared in Duchesne’s thesis 
title: Concurrence Vitale chez les Microorganismes: Antagonisme entre les Moisissures et les 
Microbes (The Struggle for Life amongst Microorganisms: Antagonism between Molds and 
Bacteria; figure 1). He observed in his introduction that the question of “la concurrence vitale” 
had only been studied closely in plants and animals. His plan to examine vital struggle in 
microorganisms had the potential to uncover valuable medical applications.16 
                                            
14 Ernest Duchesne, Contribution à l'Étude de la Concurrence Vitale chez les 
Microorganismes: Antagonisme entre les Moisissures et les Microbes (Lyon: Alexandre Rey, 
1897), 9. 
15 Darwin, who had a testy relationship with Royer, turned to Jean-Jacques Moulinié for a 
new French translation in 1873 based on the sixth and final edition of the Origin. Moulinié 
retitled chapter three “De la Lutte pour L’existance” and otherwise eliminated the phrase 
“concurrence vitale.” Royer’s translation remained popular, however. See Joy Harvey, 
“‘Strangers to Each Other’: Male and Female Relationships in the Life and Work of 
Clémence Royer,” in Uneasy Careers and Intimate Lives: Women in Science, 1789-1979, eds. 
Pnina G. Abir-Am and Dorinda Outram (New Brunswick: Rutgers University Press, 1987), 
147-171; and Bernard Lightman, “Scientific Naturalists and their Language Games,” History 
of Science 53 (2015): 395–416 
16 Duchesne, Contribution (ref. 14), 7. 
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Fig. 1. Title page of Duchesne’s thesis.  
 
This, however, was not the first use of the term in a microbiological context in French. 
In his bibliography to his thesis, Duchesne referred to work by the pathologist Albert Charrin, 
who published an article on “La concurrence vitale en bactériologie” in 1892 and the 
following year, in collaboration with a younger colleague, Arsène d’Arsonval, a paper on the 
“concurrence vitale” between the pyocyanic bacillus and beer yeast.17 Duchesne also 
acknowledged the influence of the work of Louis Pasteur. In their 1877 study of anthrax, 
Pasteur and Jules François Joubert described the inhibitory effect of certain aerobic bacteria 
on the anthrax bacillus stating that “among inferior organisms [i.e. microorganisms] more so 
than in the higher animals and plants, life prevents life” (“la vie empêche la vie”).18 Jacques 
Archimbaud views Duchesne’s work as being situated at the “confluence” of these two 
themes, and considers that of Darwin’s to be the more philosophical of the two.19  
Duchesne worked with three species of microorganism. The two species of bacteria 
he employed are somewhat easier to determine the true identity of than the species of mold 
referred to in his thesis. The former were the “bacille d’Eberth” and Bacterium coli communis. 
The first of these is Eberth’s typhoid bacillus, now referred to as Salmonella enterica serovar 
Typhimurium, and the second is Escherichia coli. The third organism Duchesne employed 
was a mold that he referred to as belonging to the species Penicillium glaucum. Pouillard has 
                                            
17 Ibid., 55. 
18 Louis Pasteur and Jules F. Joubert, “Charbon et septicémie,” Comptes Rendus de 
l'Académie des Sciences 85 (1877): 101–15.  
19 Jacques Archimbaud, “Un précurseur de la découverte de la pénicilline: Le professeur 
Gabriel Roux,” Bulletin Historique at Scientifique de l’Auvergne 88 (1976): 111–31. 
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noted that, throughout his thesis, Duchesne refers to the organism as “Penicillum.”20 Setting 
orthography aside, determining the precise identity of the mold that Duchesne worked with is 
fraught with difficulties and is considered in further detail below.  
In his first experiments, Duchesne showed conclusively that the mold was not only 
able to survive in sterile water but actually to increase in number, whereas in tap water or 
water from a public fountain the number of mold spores decreased while the number of 
bacteria present showed a corresponding increase. He summarized these experiments by 
stating that in the struggle for existence the advantage had clearly been in favor of the 
bacteria, but he wondered whether there could be circumstances where the mold could 
triumph over the bacteria, or at least neutralize its harmful effects. He demonstrated this by 
conducting experiments with guinea pigs. He injected one animal intraperitoneally with E. 
coli and reported that it died the same night. Another, injected with S. typhi, died within 
twenty-four hours. However, when he co-injected mixtures of P. glaucum with either of the 
two bacteria, the two test animals survived.21  
Finally, in the conclusion to his thesis, he speculated that his findings could lead to 
both prophylactic and therapeutic applications. His work was well received by his examiners, 
and on graduating in 1897 he undertook an internship at the Val-de-Grâce Hospital in Paris. 
Toward the end of 1898, he was appointed physician to the 2nd Regiment of Hussars based in 
Senlis. He married in 1901, but his wife died two years later of what was possibly 
tuberculosis. He himself became ill with what may also have been tuberculosis in 1904, and 
                                            
20 Pouillard, “Une découverte oubliée” (ref. 12). It should be pointed out that Pouillard 
himself makes a rather significant spelling mistake in referring to Alexander Fleming 
throughout his otherwise informative article as “A. Flemming”!  
21 Duchesne, Contribution (ref. 14), 37-40. 
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was placed on permanent sick leave in 1907. He spent the last years of his life at various 
sanatoria in the South of France and in Switzerland before dying on 30th April 1912.22 
 
Ernest Duchesne and Penicillin 
Credit for bringing Duchesne’s work to light is generally attributed to Justin Godart, who in 
February 1949 made a presentation entitled “Le précurseur français de l’action ‘antibiotique’ 
du pénicillium” (The French forerunner of the antibiotic action of Penicillium) before the 
Academie Nationale de Médecine.23 Godart, however, was certainly not the first to cite 
Duchesne’s thesis. Pouillard draws attention to a review published in 1946, which refers to 
Duchesne’s work.24 The term “forerunner” was to reappear more than once in publications 
following Godart’s use of this term in reference to Duchesne, but over time the claims made 
for Duchesne have assumed a much wider scope, and range from those that assert 
categorically that he discovered penicillin in or around 1896 to those that credit him with 
being the first to report the antagonism displayed by the penicillia toward bacteria.  
These claims exist both on websites and in print. The latter include articles in learned 
journals, specialized textbooks dealing with antibiotics and bacterial infections, popular 
science and medicine books, and newspapers. Furthermore, they vary from the almost casual 
                                            
22 Pouillard, “Une découverte oubliée” (ref. 12) 
23 Justin Godart “Le précurseur français de l’action “antibiotique” du pénicillium.” Bulletin 
de l'Académie Nationale de Médecine 133, no. 7–8 (1949): 143–46. 
24 Pouillard, “Une découverte oubliée” (ref. 12); Gaston Ramon and Rémy Richou, “De 
l'antagonisme microbien en général et en particulier des propriétés antibiotiques et 
antidotiques des filtrats de culture du B. subtilis et du Penicillium notatum à l'égard de 
certaines bactéries pathogènes et des toxines microbiennes; conséquences pratiques et 
théoriques,” Le Progrès Médical 14 (July 1946): 309–17. 
11 
 
reference,25 to those of a more polemical tone, demanding that Duchesne’s discovery be 
acknowledged.26 Too many such claims have been made on websites to attempt to analyze 
them in detail, but a few examples will illustrate the point.  
The French Wikipedia entry (in translation) “List of discoveries and inventions 
related to chance,”27 contains the following: “1928 penicillin rediscovered (well after the 
thesis of Ernest Duchesne) by Alexander Fleming.” In contrast, the entry on “La 
Pénicilline”28 states forthrightly—and with a precision that is not entirely justifiable—that 
“penicillin was discovered on 3rd September 1928 by the Briton, Alexander Fleming.” Still 
other websites choose instead to credit Professor Gabriel Roux (Duchesne’s supervisor for his 
thesis studies) with the discovery of penicillin. One such claim contains at its opening the 
resounding biblical quotation (in French), “Render therefore unto Caesar the things which are 
Caesar’s.”29  
                                            
25 Iza Radecka, Claire Martin, and David Hill, “The Problem of Microbial Drug Resistance,” 
in Novel Antimicrobial Agents and Strategies, ed. David A. Phoenix, Frederick Harris and 
Sarah R. Dennison (Weinheim: Wiley-VCH, 2015), 2. 
26 Patrice Claude, “Le découvreur de la pénicilline était francais, affirme un gentleman 
anglais,” Le Monde, July 18–19, 1999. 
27 “Liste des découvertes et inventions liées au hazard,” Wikipedia, accessed December 12, 
2015, 
https://fr.wikipedia.org/wiki/Liste_des_d%C3%A9couvertes_et_inventions_li%C3%A9es_au
_hasard  
28 “Pénicilline,” Wikipedia, accessed December 13, 2015, 
https://fr.wikipedia.org/wiki/Pénicilline Accessed 13.12.15 
29 Morgan Couturier, “Gabriel Roux a découvert l’action antibiotique de la pénicilline, 31 ans 
avant Fleming,” La Montagne, June 22, 2014, 
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The articles in learned journals generally assume a more sober and well-considered 
view of Duchesne’s contribution, but they are not entirely devoid of unsubstantiated claims. 
The historical survey of microbial antagonism by Gaston Ramon and Rémy Richou states 
that “Duchesne was the first to relate the antagonism of molds belonging to the genus 
Penicillium and bacteria.”30 Another author claims: “these facts [i.e. a summary of 
Duchesne’s findings] are sufficient to establish that Duchesne discovered not only the 
existence—but also the mechanism—of the struggle for existence between molds and 
bacteria.”31 Yet another commentator writes: “We see…that the true inventors of the action 
of penicillin on microorganisms are Professor Roux and Dr Duchesne.”32 Turning to 
textbooks, in their contribution to a survey of antimicrobial agents and strategies for 
generating novel agents, Iza Radecka and colleagues state forthrightly and without 
qualification that “penicillin was first discovered by a French medical student Ernest 
Duchesne.”33 
Similarly, in their textbook aimed at first-year chemical and bioprocessing 
engineering students, Ricardo Simpson and Sudkir K. Sastry claim that “according to the 
historical background, the person who first noticed the presence of penicillin was not 
                                                                                                                                       
http://www.lamontagne.fr/auvergne/actualite/departement/puy-de-
dome/issoire/2014/06/22/gabriel-roux-a-decouvert-laction-antibiotique-de-la-penicilline-31-
ans-avant-fleming_11051574.html. 
30 Ramon and Richou, “De l'antagonisme microbien” (ref. 24), 310. 
31 M. Rochette “M. Fleming est-il vraiment l'inventeur de la pénicilline?” L’Information 
Dentaire 37 (1955): 738–39. 
32 Delacroix D. Les precurseurs de la pénicilline. Le Concours Medical, 22 (1955): 2245–46. 
33 Radecka et al., “Microbial Drug Resistance” (ref. 25), 2. 
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Alexander Fleming but the French medical student Ernest Duchesne, in 1896.”34 Likewise, 
Duchesne features in an ANZ Journal of Surgery article on famous discoveries by medical 
students.35 In his highly acclaimed book Bad Medicine, David Wootton seeks to jointly 
apportion credit for the discovery of penicillin—but not to Fleming and Duchesne. He writes: 
“Thus it would seem fair to say that [Joseph] Lister and Duchesne had both independently 
discovered penicillin, and had taken it somewhat further than Fleming did, and that there was 
nothing remarkable in Fleming’s initial identification of penicillium [sic] as an antibiotic.”36  
The case of Duchesne also made national newspapers in France. The doctor and 
author Georges Duhamel wrote a philosophical reflection on the conditions and climate in 
which great discoveries took place for Le Figaro in the early 1950s. He was inspired to write 
the piece after having previously read the communication made by Justin Godart on 
Duchesne’s work mentioned above. He too reiterated Godart’s assessment that Duchesne was 
in effect a “précurseur” of what was to follow as a result of Fleming’s work. Duhamel went 
on to say that the conditions and attitudes prevalent in the West and in Europe, and the 
Mediterranean region in particular, made it in effect the crucible for great discoveries.37  
By writing for a national newspaper, Duhamel was able to promulgate the story of 
Duchesne much more widely than had been achieved by previous contributors to learned 
journals. More intriguing is the article entitled “Le découvrer de la pénicilline était francais, 
affirme un gentleman anglais” (The discoverer of penicillin was a Frenchman affirms an 
                                            
34 Ricardo Simpson and Sudkir K. Sastry, Chemical and Bioprocess Engineering: 
Fundamental Concepts for First-Year Students (New York: Springer; 2013), 261. 
35 Mark D. Stringer and Omid Ahmadi, “Famous Discoveries by Medical Students,” ANZ 
Journal of Surgery 79 (2009): 901–8. 
36 David Wootton, Bad Medicine (Oxford: Oxford University Press, 2007), 248.  
37 Georges Duhamel, “Conditions et climat de la découverte,” Le Figaro, July 20, 1951. 
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English gentleman), which appeared in Le Monde in 1999.38 The author Patrice Claude 
begins by imagining Alexander Fleming, the “official discoverer of penicillin,” to be turning 
in his grave. The titular gentleman, Richard Barry, we are told, had apparently consulted 
numerous articles including Duchesne’s thesis in support of his claim. Aware that Duchesne 
died childless, Barry hoped that there might be family members—perhaps nieces or 
nephews—reading his article who might feel induced to contact him with further information 
about their relative. Failing that, he hoped that a will of Duchesne’s might exist and be 
brought to light. Quite what such a will might contain would be impossible to imagine…. 
The ways in which the achievements of scientists are celebrated and credit is awarded 
to them for their discoveries is the subject of an article by Janet Browne, who took as her 
example Charles Darwin.39 One of the themes she explored was the “material record of 
celebrity,” which includes visual imagery. Imagery has been used quite extensively to 
promulgate the story of penicillin to a wider audience. One of the means by which this has 
been achieved is through the issuing of postage stamps. It is not the intention to include here 
a complete survey of the depiction of the discovery of penicillin in philately, as this has 
already been ably undertaken.40 However, it is relevant to record here that the Principality of 
Monaco issued a postage stamp in commemoration of the one-hundredth anniversary of 
Ernest Duchesne’s birth in 1974.  
 
                                            
38 Claude, “Le découvreur de la penicillin” (ref. 26). 
39 Janet Browne, “Commemorating Darwin,” British Journal for the History of Science 38 
(2008): 251–74. 
40 Étienne Jouzier, “Découverte de la pénicilline et philatélie,” Bulletin de la Société de 
Pharmacie de Bordeaux 141 (2002): 181–94. 
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Fig. 2. Figure 2 Postage stamp commemorating the centenary of Duchesne’s birth issued in 
1974.  
 
As figure 2 shows, there is no reference to penicillin and no overt claims are made. 
The stamp comprises simply a portrait of Duchesne set aside a drawing of the conidiophores 
of Penicillium. Jos Houbraken, a taxonomist specializing in the penicillia, informs me that the 
drawing does not enable the species of Penicillium to be determined—a fact that, as is 
discussed below, turns out to be quite prophetic. In 2003, the seventy-fifth anniversary of 
Fleming’s discovery of penicillin, and possibly in an attempt to redress the balance, Monaco 
issued a stamp depicting Alexander Fleming bearing the caption “Discovery of penicillin in 
1928.” Although the fact that websites and newspaper articles contain errors should not come 
as a surprise, less excusable is the somewhat offhand manner in which the textbooks and 
journal articles cited above misrepresent the process of discovery itself.41 This is considered 
further below. 
 
A (Very) Brief History of the Origins of Microbial Antagonism 
Much has been written about the therapeutic use by a number of widely different ethnic 
cultures in times past of a variety of substrates that had been allowed to spontaneously 
become moldy.42 The persistence in the use of such folk remedies to treat superficial 
infections would tend to suggest that they possessed, at the very least, some therapeutic 
benefit. Alexander Fleming was certainly not the first person to witness microbial antagonism 
                                            
41 For reflection on how science textbooks alter history, see Allan Franklin, “Physics 
Textbooks Don’t Always Tell the Truth,” Physics in Perspective 18 (2016): 3-57 
42 See for example Milton Wainwright, “Molds in Ancient and More Recent Medicine,” 
Mycology 3 (1989): 21–23. 
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in a more controlled setting, but nor was Duchesne. The review of the phenomenon of 
microbial antagonism conducted by the French scientists Ramon and Richou,43 mentioned 
above, takes as its starting point the work of Joubert and Pasteur conducted in 1877, which 
demonstrated that the growth of the anthrax bacillus could be inhibited by other bacteria. In 
an exhaustive review of antibacterial chemotherapy, George N. Rolinson cites the even 
earlier work of John Burdon Sanderson.44 Sanderson, a pioneering medical officer of health 
in London, observed in 1871 that bacteria failed to develop in media in which there was 
visible growth of Penicillium mold. In late 1871 and early 1872, Joseph Lister witnessed the 
inhibition of bacterial growth by Penicillium. Furthermore, in 1884 Lister actually treated a 
case of gluteal abscess by applying culture fluid from P. glaucum.  
In a study of the contribution to antibiosis by the biologist Thomas Huxley, James 
Friday states that Huxley first took up an interest in Penicillium in 1870.45 Huxley initially 
conducted a study of the available literature, and then began investigations on the various 
growth stages of the organism. He only pursued these studies sporadically, but in 1875 he 
began a correspondence with the polymath physicist John Tyndall. Tyndall had been 
investigating light, airborne particulate matter and putrefaction. The two began sharing 
information about their experiments. Working with turnip infusions, Tyndall found that 
bacteria were inactivated in those infusions in which mold was growing abundantly. He 
attributed this to the Penicillium depriving the bacteria of oxygen, but Huxley, having 
                                            
43 Ramon and Richou, “De l'antagonisme microbien” (ref. 24). 
44 George N Rolinson, “From Pasteur to penicillin—the history of antibacterial 
chemotherapy,” Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene Serie A 267 
(1988): 307–15. 
45 James Friday, “A Microscopic Incident in a Monumental Struggle: Huxley and Antibiosis 
in 1875,” The British Journal for the History of Science 7 (1974): 61–71. 
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repeated Tyndall’s experiments, apparently disagreed with this interpretation simply stating 
that he (Huxley) had “verified Sanderson’s results.”46 Similarly, in 1874, the physician and 
physiologist William Roberts claimed that he “had repeatedly observed that liquids in which 
the Penicillium glaucum was growing luxuriantly could with difficulty be artificially infected 
with Bacteria.”47 
Scientists initiated the study of microbial antagonism in the 1870s. Moreover, as the 
above demonstrates, there was an element of simultaneity in such investigations. As to what 
might have been the motivating factors in these investigations, the development of 
experimental physiology and the microbiology of Pasteur raised questions and offered 
powerful new research methods to answer them. The appearance of Darwin’s On the Origin 
of Species in 1859 must surely also have been key, as it was to be years later for Duchesne. It 
would seem to be highly unlikely that Duchesne would have been aware of any of the 
investigations mentioned above and carried out in Britain. 
Finally, it should not be assumed that what might be thought of as the extension of the 
early observations of microbial antagonism discussed above was solely conducted by 
Fleming. In 1939, René Dubos isolated what he termed “tyrothricin” from the bacterium 
Bacillus brevis and which he showed had useful antibacterial properties.48 Also at this time, 
Selman Waksman reported on the antibacterial action of actinomycin produced by a species 
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of Actinomyces.49 Although both were to prove too toxic for systemic use, this period marks a 
turning point in the fight against infectious diseases, and Selman Waksman and Albert Schatz 
would eventually isolate streptomycin in 1944. 
 
Duchesne’s Mold and the Taxonomy of the Penicillia 
This section considers whether the designation that Duchesne assigns to the mold he 
employed in his investigations—P. glaucum—is taxonomically meaningful and can be of use 
in establishing whether or not it produced penicillin.  
A 1979 monograph on the genus Penicillium by John I. Pitt opens with the 
observation that “rare indeed must be the human individual who has not encountered fungi of 
the genus Penicillium.”50 They are of course readily visible as greenish growths on fruits, 
stored grain, wood, and paper. Systematic study of fungi can be dated to the era of Linnaeus, 
and according to the mycologists Kenneth Raper and Charles Thom,51 the earliest known 
illustration unmistakably representing Penicillium occurs in the work of the botanist Pierre 
Bulliard in 1790. Bulliard actually refers to it as “Mucor penicillatus” (figure 3).52 Heinrich 
Friedrich Link first applied the name “Penicillium” to a genus of fungi in 1809. Link 
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described three species, including P. glaucum (figure 4).53 Later, in 1874, Oscar Brefeld 
published a “life history” of P. glaucum with drawings, but Kenneth B. Raper and Charles 
Thom point out that nowhere in Brefeld’s study is the species adequately described.54 This 
led to the tendency to assign virtually all green molds to the species P. glaucum, one which 
came to be roundly condemned by subsequent generations of mycologists.  
 
Fig. 3. This drawing by Pierre Bulliard is the earliest known illustration of a Penicillium 
(1790). “Mucor penicillatus” is shown in Fig XI. Credit: Reproduced with the kind 
permission of the Director and the Board of Trustees, Royal Botanic Gardens, Kew. 
 
Fig. 4. Drawing by Heinrich Friedrich Link of Penicillium glaucum (depicted in figure 24). 
Source: Reproduced with the kind permission of the Director and the Board of Trustees, 
Royal Botanic Gardens, Kew. 
 
In his Handbook on Moulds, Yeasts and Actinomycetes, which first appeared in 
1930,55 the mycologist Arthur Henrici decried the earlier literature for referring to “species” 
(his quotes) without an accurate determination of identity. He went on to say that “all green 
forms” were often referred to as P. glaucum, and that because this designation had been used 
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so indiscriminately for a wide variety of different species, it had become worthless and its use 
should be avoided. Nothing illustrates the fluidity in the designation of the names of species 
by taxonomists more than the changing identity of the mold that Fleming first isolated—
surely the most celebrated species of the entire genus.56 All the standard Fleming biographies 
refer to the early misidentification of Fleming’s isolate made by Charles La Touche, who 
classified it as P. rubrum.57 Subsequently, the American mycologist Charles Thom 
reclassified it as P. notatum.58 Later, Robert Samson and his collaborators broadened the 
definition of P. chrysogenum to include P. notatum,59 a move which Jos Houbraken and his 
co-authors state has been widely upheld by subsequent publications on the genus. Most 
interesting in the current context is their claim that the correct designation of Fleming’s strain 
should in fact be P. rubens—orthographically at least very close to La Touche’s original 
designation!  
In a 2013 article, fungal biologist Nicholas Money inveighs against what he terms the 
“Linnean fantasy of a divine order throughout nature” and the “shackles of Linnaean 
fundamentalism.”60 Pointing to the difficulties of even defining what constitutes a fungal 
species, he advocates instead the digital barcoding of fungi based on DNA sequencing. This 
view is somewhat revolutionary and is bound to provoke controversy, but pending resolution 
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of these fundamental points at issue, we are obliged to adhere to the binominal system of 
referring to fungal species while both acknowledging and accepting its limitations. A recent 
review estimates that there are currently 354 species belonging to the genus Penicillium.61 
Prior to this, it had been claimed that there were eight species in the section Chrysogena, 
which is contained within the genus Penicillium, which produce penicillin.62 
As the foregoing demonstrates, the designation “P. glaucum” is essentially invalid, 
and of no help in attempting to establish whether a strain bearing this name produces 
penicillin. Nowhere in Duchesne’s thesis does he indicate the origin of the strain he used, and 
moreover, the practice of depositing microbial strains in culture collections was virtually 
unheard of at the time in which Duchesne undertook his work—the first culture collection 
having been established only in 1890 at the German University of Prague.63 There are, 
therefore, no prospects of being able to repeat Duchesne’s experiments.  
 
Antibacterial Compounds Produced by the Penicillia 
Once Fleming had isolated the mold that had contaminated his petri dish, he proceeded to 
grow it in liquid culture so that he could determine the extent of its antibacterial properties 
against a wider range of bacteria. To do so he had first to separate the mold biomass from the 
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broths in which the mold was cultured, and, in his own words, “for convenience and to avoid 
repetition of the cumbersome phrase ‘mould broth filtrate’ the name ‘penicillin’ will be 
used.”64 An assessment of this act of Fleming’s made by the botanist Jules Brunel in 1944—a 
time during the Second World War when media interest in penicillin was at its peak65—is 
worthy of consideration here.66 Brunel cites Fleming’s coining of the name penicillin as the 
reason why Fleming, rather than any of the previous witnesses to microbial antagonism, 
achieved fame. But this is to misinterpret Fleming’s action; it is clear that from the outset that 
Fleming envisaged a specific chemical entity—the what in Kuhn’s usage. In an interview 
Fleming granted The Scotsman newspaper a decade after his original observation, he said that 
penicillin was “probably a quite simple chemical, and it could be made in the same way as 
sulphonamide.”67 Of all the individuals mentioned above (including Duchesne) who 
witnessed microbial antagonism, only Tyndall postulated a mechanism by which the 
phenomenon manifested itself. To recall, he believed—wrongly as it turned out—that the 
mold was depriving the bacteria of oxygen.  
It was later to emerge that the penicillins are in fact a family of compounds. This was 
first realized in 1943 when British and American researchers independently came up with 
different chemical formulae for penicillin. Further investigation revealed that the strains of 
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Penicillium being used on either side of the Atlantic were in fact producing different 
penicillins; the American material was termed “Penicillin G” and the British one “Penicillin 
F.”68 There are in fact some half dozen naturally occurring penicillins. They differ only in the 
nature of the acyl side chain that is attached to the defining feature of the penicillins—the 
beta-lactam ring fused to a thiazolidine ring. 
Penicillin belongs to a class of compounds that have traditionally been referred to as 
“secondary metabolites.” There are a number of definitions of just what this term signifies, 
but for the present purposes they can be thought of as compounds which confer certain 
advantages to the organisms producing them, but which are not indispensable to their 
function and survival as would be primary metabolites which are associated with the cell’s 
requirement for energy and nutrients.69 In the recent literature, the new coinage “extrolite” 
appears to be displacing the term “secondary metabolite.” An extrolite has been defined as 
“an outwardly directed chemical compound produced during differentiation of a living 
organism.”70 An extrolite is usually excreted, but can also be accumulated in the cell wall or 
membrane. The molds as a group produce a huge array of extrolites. A recent estimate sets 
the number produced by the genus Penicillium alone as 1,338.71 Included are compounds 
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exhibiting antibacterial action as well as those that are termed “mycotoxins.” The distinction 
between them is not always clear cut: a number of compounds over the years having potent 
antibacterial properties have been isolated only to prove upon further testing to be too toxic 
for therapeutic use.  
That certain extrolites could exhibit antibacterial properties but prove toxic was 
brought to light in an investigation conducted toward the end of the Second World War in a 
study on antibiotics other than penicillin produced by the penicillia.72 This study provided 
data on the chemical characteristics, antibacterial potency, and toxicity of the following 
compounds: clavicin, penicillic acid, spinulosin, penatin, citrinin, and puberulic and 
puberulonic acids. The toxicity data presented in this work had been conducted using a 
variety of animals including mice, chicks, and guinea pigs. These investigators concluded 
that most of these compounds—with the possible exception of penicillic acid—were possibly 
too toxic for therapeutic use. Later, H. Stowar Burton of Oxford’s Sir William Dunn School 
of Pathology published his findings on the production of antibiotics by the penicillia.73 He 
found antibacterial substances in the culture fluids of thirteen species of Penicillium. These 
comprised phoenicin, expansin, mycophenolic acid, penicillic acid, and herquein. In contrast 
to the earlier study mentioned above, he did not conduct tests for toxicity. However, he 
showed that some species produced “penicillin-like substances” and that furthermore, certain 
species were able to produce more than one antibiotic simultaneously.74 
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Some of the duplication of effort, and confusion over the identity of antibacterial 
compounds studied in this period, was later unpicked by Ronald Bentley and J. W. Bennett, 
who cite the case of clavacin.75 This compound was first isolated by Salman Waksman in 
1943, but was later obtained independently by other investigators and variously given the 
names claviformin, expansin, mycoin c, and penicidin. The compound in question is now 
referred to as “patulin” and is classified as a carcinogen.76 It has emerged that, during the 
Second World War, a number of covert attempts to manufacture penicillin were undertaken 
in Occupied Europe.77 One such attempt was made at the Botanisch Laboratorium in Utrecht, 
where researchers had heard about penicillin from a number of different sources—including 
leaflets dropped over the country by the Royal Air Force—and attempted to undertake its 
production using a strain of P. expansum. However, postwar investigations revealed that 
although the active substance these workers had been producing did possess some therapeutic 
value in treating superficial infections, it was too toxic for parenteral administration, and that 
in all probability it was in fact patulin.78  
As mentioned above, individual species of mold are able to produce a range of 
secondary metabolites, including a number of antibiotics, simultaneously. The propensity of 
P. chrysogenum to do so was rigorously investigated at the genetic level in a recent study in 
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which strains isolated from the environment (including Fleming’s strain and a highly 
productive one isolated during the Second World War in Peoria, Illinois)—and referred to as 
“wild types”—were compared with industrially employed strains that had been subject to 
intensive campaigns of mutagenesis and selection since the early 1940s.79 Although such 
campaigns had led to enormous increases in the yields of penicillin produced, the researchers 
established that the impact of such strain development programs was to drastically reduce the 
number of extrolites produced compared to that of the wild-type “parent” strains. The factors 
influencing the constituents of the “cocktail” of antibacterial compounds produced by wild-
type isolates would be those of temperature, pH, and composition of the growth medium. 
 
Penicillin Toxicity Tests on Animals 
In experiments carried out during the Second World War on the treatment of gas gangrene in 
guinea pigs with penicillin, researchers noted that all the animals died without showing 
symptoms of gas gangrene. This prompted a study of the toxicity of penicillin toward mice, 
rabbits, and guinea pigs.80 It was established that doses of penicillin that were tolerated by 
mice and rabbits resulted in the death of guinea pigs. Work carried out at Cornell University 
Medical College and the New York Hospital by Frank E. Cormia, George M. Lewis, and 
Mary E. Hopper with a large sample size of 58 guinea pigs confirmed the earlier findings of 
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the toxicity of penicillin towards this particular species, and identified the cause of death as 
damage to the adrenal gland. Furthermore, they showed that penicillin preparations of higher 
purity were associated with increased toxicity toward all animals. The researchers first 
presented their results in 1947 to the Eighth Annual Meeting of the Society for Investigative 
Dermatology. In the subsequent discussion at the meeting, the distinguished dermatologist 
Marion Sulzberger made the following observation: “If Fleming and his followers had tested 
penicillin for toxicity by first performing the customary toxicity assays on guinea pigs, they 
would have been forced to the costly error of concluding that therapeutically effective doses 
would be too toxic for use in human diseases. And the discovery of penicillin, one of the 
greatest medical advances of all time, would have been lost to mankind if the species homo 
had responded to penicillin injections as do the guinea pigs.”81  
Although there is no record of Fleming ever having conducted tests of toxicity on 
animals, there is certainly something to Sulzberger’s assessment. As the team at Oxford 
under Howard Florey began building up their production of penicillin, they undertook 
toxicity tests using mice, rats, cats, and rabbits.82 The absence of untoward effects in these 
animal species gave them the confidence to progress to in vivo studies. The first experiment 
involving bacterially infected animals that Howard Florey and his colleagues conducted on 
May 25, 1940, and which was to definitively reveal the therapeutic potential of penicillin, 
was performed using mice.  
 
Was Duchesne Working with Penicillin? 
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It has occasionally proved possible to go some way toward inferring the identity of an 
antibiotic described in the early literature. For example, George N. Rolinson points out that 
Lister observed that filtrates of his Penicillium culture led to the development of abnormal 
morphology—something which Fleming was apparently fond of demonstrating using his 
culture broths.83 He deduces from this that Fleming might not have been the first to observe 
the effects of penicillin. However, there are no such leads in the case of Duchesne. And as 
was demonstrated above, it is not possible to pinpoint the species from the designation “P. 
glaucum” in order to attempt to reconstruct Duchesne’s experiments. As was also mentioned, 
350 species of Penicillium are now formally recognized, only eight of which produce 
penicillins. Furthermore, it was pointed that a total of 1,338 extrolites produced by the genus 
Penicillium have been identified and characterized. By no means will all of these extrolites 
possess antibacterial properties. Moreover, of the portion that do, some will prove themselves 
to be too toxic for therapeutic purposes.  
On a purely probabilistic basis, therefore, the likelihood that Duchesne was working 
with a penicillin-producing strain becomes vanishingly low. However, there exists one piece 
of evidence that rules out the possibility altogether. This lies in the species of animal that 
Duchesne used in his in vivo experiments: these were guinea pigs, which, as was revealed 
above, were discovered in the 1940s to display an extreme sensitivity to penicillin—one that 
could lead to their death. Yet, all of the guinea pigs that Duchesne treated with his 
preparations survived.  
Duchesne’s thesis reports that he injected the guinea pigs he used in his experiments 
with whole cultures of P. glaucum containing fungal mycelium in suspension in the broth, 
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which would have contained the extrolites produced by the mold. It is possible that the fungal 
mycelium may have stimulated the animals’ innate defenses and this may have contributed to 
their survival. The fungal cell contains a number of components that have been shown to 
stimulate such a response. When such compounds are given in combination with antibacterial 
agents they are referred to as “adjuvants.” A recent review has shown that when 
polysaccharides from the fungal cell wall known as β-glucans are given in combination with 
vaccines enhanced protection is conferred.84 The above should not be interpreted as implying 
that the presence of fungal mycelium in the broths injected into the guinea pigs would have 
counteracted the directly lethal effects of penicillin had it been present, and therefore the case 
against Duchesne is not compromised.  Rather, a possibility exists, albeit a slim one, that the 
mycelium may have acted in combination with antibacterial extrolites present in Duchesne’s 
broths to supplement their effects.   
 
 
 
 
 
 
 
 
 
 
                                            
84 Stuart M. Levitz, Haibin Huang, Gary R. Ostroff, and Charles A. Specht, “Exploiting 
Fungal Cell Wall Components in Vaccines,” Seminars in Immunopathology 37 (2015): 199–
207. 
30 
 
 
 
 
 
Discovery and its Context 
It is appropriate to examine here why Fleming’s status as the discoverer of penicillin has 
never been fully accepted in some quarters. The answer lies in part in Fleming’s own account 
of the circumstances leading to the discovery. In his article on penicillin he writes: “While 
working with staphylococcus variants a number of culture-plates were set aside on the 
laboratory bench and examined from time to time. In the examinations these plates were 
necessarily exposed to the air and they became contaminated with various micro-
organisms.”85 That is, the contamination by the Penicillium mold was purely accidental, and 
therefore Fleming just happened to be lucky. The other important consideration is what 
Fleming came to reveal about himself and his work in the many talks and interviews he gave 
when penicillin was starting to become a household word: he admitted to “playing” with 
microbes. An accident is by definition an unforeseen incident, and on this basis an accident 
could happen to anybody. The implication of this for accidental discoveries in science is that 
the supposed discoverer has somehow not earned the title through protracted and painstaking 
investigation, but was merely graced by the good fortune of being in the right place at the 
right time.86 In particular, and in contrast to Duchesne, Fleming was not engaged in 
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investigating microbial antagonism. The nature of the investigations he was undertaking in 
the late summer of 1928 was, and remains, unknown. 
Robert Root-Bernstein reveals that Fleming’s laboratory notebook was of the loose-
leaf variety and that the pages covering the time in question are missing.87 He suggests that 
they were either mislaid or deliberately destroyed. He then goes on to conjecture that Fleming 
may have been investigating the possibility that the mold that contaminated his petri dish was 
producing lysozyme. In 1922, Fleming had discovered that a number of bodily fluids contain 
a compound able to lyse certain bacteria and he named it “lysozyme.” Fleming continued 
working on lysozyme into the 1930s and showed that it was present in the organs and tissues 
of a variety of animal species. Root-Bernstein cites this as evidence that discovery is a 
process rather than an event. The attempts to credit Duchesne with the discovery of penicillin 
are most objectionable not because they seek to usurp credit from Fleming, but rather because 
they distort the process by which a community of researchers in the 1940s made penicillin 
available to humankind. 
Root-Bernstein argues strongly against attaching the term “luck” to discoveries such 
as those made by Fleming, and refers to its use as the “palliative of the mediocre.”88 He then 
goes on to reconstruct the context in which Fleming made his observation, drawing on the 
years of experience and insight which he had accumulated in his time as a bacteriologist. 
During the First World War, Fleming served in the military hospital located in the municipal 
casino in Boulogne in France and was actively engaged in treating battle casualties. During 
this time he even went as far as constructing a wound model to demonstrate how ineffectual 
chemical antiseptics were at disinfecting wounds.  
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Root-Bernstein also sees as deeply significant the “playing” with microbes that 
Fleming indulged in. In particular, Fleming developed the pastime of “painting” scenes onto 
agar in petri dishes using bacteria of different colors as his pigments—a mother and child, a 
soldier in the Life Guards. As Root-Bernstein has pointed out, he had first to isolate his 
“palette” and then form an appreciation of the conditions under which the microorganisms 
(most probably both bacteria and yeasts) would develop their pigments. He streaked bacteria 
of different colors alongside one another—an action requiring a certain confidence and 
sureness of action, as the colors would have only become visible after incubation. But much 
more important than the physical deftness this required Root Bernstein argues, is the high 
probability that he would have encountered situations in which one “color” would simply not 
develop alongside another due to inter-bacterial or yeast-bacterial antagonism.  
All this accumulated experience and knowledge must have coalesced in Fleming’s 
mind when on that fateful summer’s day in 1928 he reached out to pick up that (now 
celebrated) petri dish. Fleming may be viewed as being partly responsible for the 
misinterpretation made in certain quarters of his true contribution. There would seem to be 
much riding on the verb “playing” that Fleming used when giving interviews to the media. 
He was perhaps simply trying to make his modus operandi intelligible to an audience 
comprising the public at large; however, it has tended to be interpreted by some that he was 
simply amusing himself in the laboratory.  
Is it to Fleming alone that credit should be granted for the discovery of penicillin? He 
observed that colonies of S. aureus in the vicinity of the Penicillium had been lysed—the that 
in Kuhn’s terminology—and he formed the concept that the mold was producing a compound 
that diffused through the agar and was the cause of the bacterial lysis—the what. He 
examined the extrolites of molds from other genera and found that only one of these—
33 
 
belonging to the genus Penicillium—showed inhibitory effects against bacteria.89 Moreover, 
he attempted to isolate the active principle, that is the penicillin, and failed, but this does not 
detract from the fact that he had correctly interpreted what was taking place.  
Isolation of penicillin from culture broths came to be achieved a decade later by 
Florey and his team at Oxford. In addition, as Wainwright has pointed out, Fleming, in 
contrast to the succession of individuals before him who had observed the phenomenon of 
microbial antagonism, preserved his culture of mold and freely made it available to anyone 
who applied to him for it.90 When the researchers at the Sir William Dunn School in Oxford 
decided to investigate penicillin, they actually had a culture of the Fleming strain available to 
them on their premises. It was this culture that was first used to produce penicillin for 
therapeutic purposes in both Britain and the United States and from which the chemical 
structure of the penicillins was elucidated. From this structural information was to emerge the 
concept of the “semi-synthetic penicillins,” which, despite evidence of increasing bacterial 
resistance, remain a mainstay in combating bacterial infections today.  
This article opened with the letter Almroth Wright had written to The Times 
newspaper in which he sought to award credit to Fleming for the discovery of penicillin. It is 
relevant to add here that this letter elicited a response from Robert Robinson, Waynflete 
Professor of Chemistry at Oxford University.91 Without seeking to deprive Fleming of his 
due—the laurel wreath crown—Robinson pointed out that it was Florey and his team at 
Oxford who had been responsible for isolating “therapeutic penicillin,” and that this act 
merited a bouquet, and a handsome one at that.  
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Fig. 5. A fifty-dollar Australian banknote depicting Howard Florey, which was in circulation 
from 1973 to 1995. 
 
This sequence of events was recognized by the Nobel Committee when, in 1945, they 
awarded the Nobel Prize for Physiology or Medicine jointly to Fleming, Florey, and Chain. 
Reference was made above to the uses to which visual imagery has been put in promulgating 
scientific discoveries. Florey’s achievements with reference to penicillin were 
commemorated in his native land of Australia by the issue of a fifty-dollar banknote that was 
in circulation from 1973 to 1995. Alongside his portrait is a cascade of images. These, as is 
discussed below, both provide an accurate depiction of the process leading to therapeutic 
penicillin and seek to acknowledge the contributions of others in this process. The uppermost 
image is a reproduction of Fleming’s original petri dish—a direct allusion to the observation 
which initiated the process. Below this are two white mice—a reference to the in vivo 
experiment conducted in Oxford on May 25, 1940, with purified penicillin, which was to 
definitively demonstrate penicillin’s therapeutic potential. Included below, and slightly to the 
left of the mice, is a representation of the assay developed by the biochemist Norman Heatley 
for accurately determining the titre of penicillin solutions. Alongside the latter are mature 
colonies of penicillia on a semi-solid medium. This could possibly allude to the extensive 
search undertaken for strains of P. notatum able to produce higher yields of penicillin than 
Fleming’s original isolate. As it happens, a strain found growing on a piece of melon in 
Peoria, Illinois was shown by microbiologists at the United States Department of 
Agriculture’s Northern Regional Research Laboratories to exceed the yield of penicillin 
produced by the Fleming strain when grown under the much more efficient method of 
cultivation which is referred to as “submerged culture.” The banknote also carries an image 
of bookshelves lined with antique tomes, and which may be taken as implying a nexus with 
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knowledge that predates even Fleming’s original observation and publication of his paper on 
penicillin of 1929. Also included are references to the lieu where Florey’s work on penicillin 
was undertaken: a reproduction of the inscription that appears on the lintel above the entrance 
to the Sir William Dunn School of Pathology. The recognition awarded to Florey by the 
University of Oxford in appointing him Provost of Queen’s College, Oxford in 1962 is 
signified by an image of the window of the College Library and of a statue from the Fellows’ 
Garden  
 
Duchesne’s Achievements 
Duchesne did succeed in conducting a competent investigation of microbial antagonism—
although this was, as has been demonstrated in reviews of the phenomenon, not the first of its 
kind. Many commentators have described that section his thesis where, having shown that 
molds in natural water sources are overcome by bacteria, he frames the question as to 
whether this situation might be reversed, as prophetic. There can be no doubt that Duchesne’s 
mold strain did produce one or more antibacterial compounds. Moreover, following the in 
vivo experiments that he conducted, he had the foresight to predict the therapeutic potential in 
the phenomenon under investigation. Duchesne never published his findings, and indeed, 
Serge Duckett has brought to light the fact that when Gabriel Roux was seeking appointment 
to a Chair of Parasitology and Microbiology, he did not include in his CV Duchesne’s thesis 
among the list of important theses that he had supervised.92  
In considering the criticisms that have been leveled against Duchesne for not pursuing 
his findings further, Archimbaud points out that Duchesne did not possess ambitions to 
become a professional research scientist, but saw the act of gaining his doctorate as helping 
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him to pursue a career in military medicine.93 There is no evidence that Roux did not value 
Duchesne’s work; instead, Archimbaud paints a portrait of Roux as a man immersed in a 
number of truly diverse research interests that extended to anatomy, histology, zoology, 
botany, geology, epidemiology as well as practical aspects of hygiene. Another consideration 
he suggests that might have had some bearing on this matter is that, in addition to suffering 
from a variety of physical ailments, Roux was also prone to fits of depression. 
Notwithstanding such considerations, an elapse of some fifty years was to occur before 
Duchesne’s work was rediscovered.  
 
Les Derniers Mots 
The title of this piece is avowedly Fontainesque, and therefore it would seem fitting that the 
last words should be those of La Fontaine himself. They are offered here in tribute to Ernest 
Duchesne and the others who since the late nineteenth century observed and investigated the 
phenomenon of antimicrobial antagonism. They constitute advice to moisissures and bactérie 
everywhere (irrespective of species). They come from the fable entitled “Le Pot de Terre et le 
Pot de Fer,” and they are; ne nous associons qu’avecque nos égaux (let us only associate 
with our equals).  
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